Trial Profile
A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 31 Mar 2023
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Mucositis; Pain
- Focus Therapeutic Use
- 04 Nov 2019 Status changed from recruiting to completed.
- 31 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 12 Apr 2016 Treatment arms changed from 2 to 1.